Total Liabilities - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GlaxoSmithKline PLC
Total Liabilities Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Total Liabilities
ÂŁ43.7B
CAGR 3-Years
-11%
CAGR 5-Years
-6%
CAGR 10-Years
3%
A
AstraZeneca PLC
NASDAQ:AZN
Total Liabilities
$64.8B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
6%
Indivior PLC
LSE:INDV
Total Liabilities
$1.7B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
13%
Hikma Pharmaceuticals PLC
LSE:HIK
Total Liabilities
$2.6B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
11%
Allergy Therapeutics PLC
LSE:AGY
Total Liabilities
ÂŁ42.6m
CAGR 3-Years
2%
CAGR 5-Years
10%
CAGR 10-Years
13%
Dechra Pharmaceuticals PLC
LSE:DPH
Total Liabilities
ÂŁ814.2m
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
13%

See Also

What is GlaxoSmithKline PLC's Total Liabilities?
Total Liabilities
43.7B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Total Liabilities amounts to 43.7B GBP.

What is GlaxoSmithKline PLC's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
3%

Over the last year, the Total Liabilities growth was -7%. The average annual Total Liabilities growth rates for GlaxoSmithKline PLC have been -11% over the past three years , -6% over the past five years , and 3% over the past ten years .

Back to Top